4 terminated. 4 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 4 | Terminated 4 |
Follow Lymphoma, Large B-Cell, Diffuse: new trials by email Literature Review of Lymphoma, Large B-Cell, Diffuse trials Research Report on Lymphoma, Large B-Cell, Diffuse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Imaging Apoptosis for Lymphoma Treatment Response 18F-FluorApoTrace - Diffuse Large B Cell Lymphoma | Early Phase 1 | Terminated | Washington University School of Medicine | 12 | 2021-12-06 | 2024-05-30 |
| Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies Allogeneic Hematopoietic Stem Cell Transplantation, Irradiated Allogeneic Cells - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia in Remission | Early Phase 1 | Terminated | Rutgers, The State University of New Jersey | 2 | 2020-10-26 | 2023-06-26 |
| Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma Pegfilgrastim, Loratadine, Placebo - Lymphoma | Early Phase 1 | Terminated | M.D. Anderson Cancer Center | 1 | 2015-12-14 | 2019-04-23 |
| Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma oblimersen sodium, rituximab, cyclophosphamide - Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma | Early Phase 1 | Terminated | University of Nebraska | 37 | 2008-07-23 | 2023-10-24 |
Lymphoma, Mantle-Cell (2) · Lymphoma, T-Cell (2) · Burkitt Lymphoma (1) · Chromosome 17 deletion (1) · Hematologic Neoplasms (1) · Lymphoma (1) · Lymphoma, Extranodal NK-T-Cell (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1) · Neoplasm, Residual (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Lymphatic Diseases (4) · Lymphoma, B-Cell (4) · Lymphoproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Lymphoma (3) · Lymphoma, Non-Hodgkin (3) · Blood Protein Disorders (1) · Bone Marrow Diseases (1) · Cardiovascular Diseases (1) · DNA Virus Infections (1) · Epstein-Barr Virus Infections (1)
Biopsy (1) · Cyclophosphamide (1) · Cytogenetic Analysis (1) · Doxorubicin (1) · Gene Expression Profiling (1) · Immunohistochemistry (1) · Loratadine (1) · Microarray Analysis (1) · Prednisone (1) · Rituximab (1) · Sugars (1) · Surveys and Questionnaires (1) · Vincristine (1) · oblimersen (1) · pegfilgrastim (1)
M.D. Anderson Cancer Center (1) · Rutgers, The State University of New Jersey (1) · University of Nebraska (1) · Washington University School of Medicine (1)
United States (4)
Farrokh Dehdashti, M.D. (1) · Jason R. Westin, MD (1) · Julie M Vose, MD MBA (1) · Roger Strair (1)
P30CA036727 (1), P30CA072720 (1)